Related Experiment Video

Updated: Jun 3, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of

Benjamin S Scruggs1, Yiqin Zuo, Ellen Donnert

  • 1Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

The American Journal of Pathology
|March 17, 2011
PubMed

Insights

Angiotensin type 1 receptor blockers (ARBs) promote capillary growth in the glomerulus, increasing branching and network complexity. This capillary remodeling contributes to the regression of glomerulosclerosis in chronic kidney disease.

Area of Science:

  • Nephrology
  • Renal Pathophysiology
  • Vascular Biology

Background:

  • Chronic kidney disease (CKD) involves progressive glomerulosclerosis and tubulointerstitial fibrosis.
  • Angiotensin type 1 receptor blockers (ARBs) can regress glomerulosclerosis, partly by reducing matrix accumulation.
  • Mechanisms underlying glomerular capillary remodeling during sclerosis regression are not fully understood.

Purpose of the Study:

  • To investigate if capillary branching is enhanced in glomeruli showing ARB-induced sclerosis regression.
  • To explore the topological changes in the glomerular capillary network following ARB treatment.

Main Methods:

  • Utilized three-dimensional confocal imaging of rat glomeruli.
  • Applied graph theory analysis to assess glomerular capillary network topology.
  • Compared glomerular structure in normal, sclerotic, and ARB-treated rats.

Main Results:

  • Glomeruli with progressive sclerosis showed reduced capillary segments, branch points, and network complexity.
  • ARB treatment led to increased glomerular capillary segments and branch points.
  • Restored glomerular network complexity and enhanced capillary branching were observed in ARB-treated rats.

Conclusions:

  • Capillary growth, characterized by increased branching and network complexity, contributes to sclerosis regression in CKD.
  • Angiotensin type 1 receptor blockers (ARBs) mediate this capillary remodeling.
  • These findings elucidate a key mechanism in ARB-induced regression of glomerulosclerosis.

More Related Videos

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...